Search - tctmd.com

Displaying 481 - 500 of 647

Sort: Relevancy | Date

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

Presentation SCAD 2018

How should we design future SCAD trials?

Presenter: Karin H Humphries

September 08, 2018

News Daily News

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

Todd Neale

September 07, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

Todd Neale

August 26, 2018

News Daily News

After Cardiotoxic Chemo, Less Than Half of Women With Breast Cancer Get Recommended Monitoring

Caitlin E. Cox

August 06, 2018

News Daily News

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

Todd Neale

July 20, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Daily News

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Yael L. Maxwell

June 25, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Industry News

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

May 17, 2018

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

L.A. McKeown

May 15, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

News Conference News EAS 2018

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

LPA Variants Linked With CHD Events in Statin-Treated Patients

Michael O'Riordan

May 03, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

Advertisement

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

How should we design future SCAD trials?

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

After Cardiotoxic Chemo, Less Than Half of Women With Breast Cancer Get Recommended Monitoring

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

LPA Variants Linked With CHD Events in Statin-Treated Patients

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content